Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heli Siitonen

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Seminars in Reproductive Medicine|May 16, 2025
Progestogens in Menopausal Hormone Therapy: A Double-Edged SwordOlavi Ylikorkala, Johanna M Joensuu, Heli Siitonen, et al.
European Journal of Cancer (Oxford, England : 1990)|March 19, 2025
Update of the impact of menopausal hormone therapy on breast cancer riskHeli Siitonen, Johanna Joensuu, Hanna Savolainen-Peltonen, et al.
Maturitas|December 6, 2025
Vaginal use of estradiol is associated with a reduced risk of rectal cancer in postmenopausal women: A Finnish nationwide case-control studyHeli Siitonen, Johanna M Joensuu, Hanna Savolainen-Peltonen, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Seminars in Reproductive Medicine|May 16, 2025
Progestogens in Menopausal Hormone Therapy: A Double-Edged SwordOlavi Ylikorkala, Johanna M Joensuu, Heli Siitonen, et al.
European Journal of Cancer (Oxford, England : 1990)|March 19, 2025
Update of the impact of menopausal hormone therapy on breast cancer riskHeli Siitonen, Johanna Joensuu, Hanna Savolainen-Peltonen, et al.
Maturitas|December 6, 2025
Vaginal use of estradiol is associated with a reduced risk of rectal cancer in postmenopausal women: A Finnish nationwide case-control studyHeli Siitonen, Johanna M Joensuu, Hanna Savolainen-Peltonen, et al.
Pageof 1